Secondary mutations at I1171 in the ALK gene confer resistance to both Crizotinib and Alectinib. uri icon

Overview

publication date

  • December 1, 2014

Research

keywords

  • Bone Neoplasms
  • Brain Neoplasms
  • Carcinoma, Non-Small-Cell Lung
  • Lung Neoplasms
  • Mutation
  • Pyrazoles
  • Pyridines
  • Receptor Protein-Tyrosine Kinases

Identity

Scopus Document Identifier

  • 84926421984

Digital Object Identifier (DOI)

  • 10.1097/JTO.0000000000000358

PubMed ID

  • 25393798

Additional Document Info

volume

  • 9

issue

  • 12